Physician

Eduardo Uchiyama, M.D.

According to 2025 Medicare claims, Eduardo Uchiyama, M.D. (NPI: 1891973673) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 33308-1909.

Uchiyama's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 631 traditional Medicare patients, billed 10,810 HCPCS/CPT codes, and received $1,244,614 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 815 prescription claims across 237 beneficiaries totaling $90,764 in drug costs, led by Ilevro (Nepafenac). Open Payments data shows 145 records totaling $724,872. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $95,110 and ending at $90,764. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$716K$1.4M2015 Medicare payment: $900,485 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,158,857 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,245,267 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,431,986 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,408,545 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,430,556 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,408,482 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,376,871 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,377,305 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,244,614 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155385,077$900,485
20166296,638$1,158,857
20176377,257$1,245,267
20187068,261$1,431,986
20197418,687$1,408,545
20206748,212$1,430,556
20216907,799$1,408,482
20226707,553$1,376,871
20236759,396$1,377,305
202463110,810$1,244,614

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$108K$217K2015 Drug cost: $95,110 (USD; Tot_Drug_Cst)2016 Drug cost: $165,774 (USD; Tot_Drug_Cst)2017 Drug cost: $137,463 (USD; Tot_Drug_Cst)2018 Drug cost: $157,257 (USD; Tot_Drug_Cst)2019 Drug cost: $216,750 (USD; Tot_Drug_Cst)2020 Drug cost: $153,052 (USD; Tot_Drug_Cst)2021 Drug cost: $118,000 (USD; Tot_Drug_Cst)2022 Drug cost: $126,673 (USD; Tot_Drug_Cst)2023 Drug cost: $184,431 (USD; Tot_Drug_Cst)2024 Drug cost: $90,764 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015214724$95,110
2016255919$165,774
2017238860$137,463
2018267980$157,257
20192761,039$216,750
2020252929$153,052
2021263886$118,000
2022254852$126,673
2023261927$184,431
2024237815$90,764

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye161606$106
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more197327$103
92014Established patient complete exam of visual system473910$98
92134Imaging of retina5871,364$32
92250Photography of the retina151192$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IlevroNepafenac813,392$34,605
Bromfenac SodiumBromfenac Sodium1514,020$19,437
DifluprednateDifluprednate1134,667$11,578
Prednisolone AcetatePrednisolone Acetate1096,047$5,770
ProlensaBromfenac Sodium12353$4,282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.55$41,278Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.90$683,594Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Eduardo Uchiyama, M.D.?

Tedicare shows public-source Medicare data for Eduardo Uchiyama, M.D. (NPI 1891973673), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eduardo Uchiyama, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eduardo Uchiyama, M.D.?

Eduardo Uchiyama, M.D. is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Eduardo Uchiyama, M.D. have Open Payments data?

Eduardo Uchiyama, M.D. has 145 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.